Sanofi Pasteur Revenue and Competitors
Estimated Revenue & Valuation
- Sanofi Pasteur's estimated annual revenue is currently $3.7B per year.
- Sanofi Pasteur's estimated revenue per employee is $201,000
Employee Data
- Sanofi Pasteur has 18211 Employees.
- Sanofi Pasteur grew their employee count by -1% last year.
Sanofi Pasteur's People
Name | Title | Email/Phone |
---|---|---|
1 | Owner | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Associate VP New Vaccines Projects | Reveal Email/Phone |
4 | VP, Marketing | Reveal Email/Phone |
5 | EVP /General Manager, General Medicines and Emerging Markets | Reveal Email/Phone |
6 | EVP Legal Affairs and General Counsel | Reveal Email/Phone |
7 | Security Officer | Reveal Email/Phone |
8 | Head Engineering | Reveal Email/Phone |
9 | Head Medical operations and governance | Reveal Email/Phone |
10 | Associate VP, Head Bioprocess Research and Development North America | Reveal Email/Phone |
Sanofi Pasteur Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Sanofi Pasteur?
Sanofi researches, develops, manufactures, and markets various therapeutic solutions. The company operates in three segments: Pharmaceuticals, Vaccines, and Animal Health. It offers Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-1 receptor agonist; Toujeo, an insulin glargine; and Afrezza, an inhaled insulin. The company also provides Praluent, a human monoclonal antibody; and Multaq, a multichannel blocker with anti-arrhythmic properties. In addition, it offers Cerezyme, an enzyme replacement therapy to treat gaucher disease; cerdelga, an oral therapy for Gaucher disease Type 1; Myozyme/Lumizyme for the pompe disease treatment; Fabrazyme for fabry disease treatment; and Aldurazyme to treat mucopolysaccharidosis Type 1, as well as provides Aubagio and Lemtrada for multiple sclerosis. In addition, it provides Jevtana for prostate cancer; Taxotere for breast, prostate, gastric, lungs, and head and neck cancer treatment; Eloxatin for the treatment of stage III colon cancer; Thymoglobulin to treat acute rejection; Mozobil for treating hematologic malignancies; and Zaltrap for oxaliplatin resistant metastatic colorectal cancer. Further, the company offers other prescription drugs, such as Plavix/Iscover for atherothrombosis and acute coronary syndrome; Lovenox/Clexane for the treatment of venous thromboembolism; Aprovel/Avapro/Karvea for hypertension and nephropathy; Renagel/Renvela to treat chronic kidney disease; Allegra/Telfast to treat seasonal allergic rhinitis and uncomplicated hives; Stilnox/Ambien/Myslee for insomnia treatment; and Synvisc/Synvisc-One for the treatment of osteoarthritis pain. Additionally, it offers consumer health care products and generic medicines; and vaccine and animal health products. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
keywords:N/AN/A
Total Funding
18211
Number of Employees
$3.7B
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sanofi Pasteur News
Sanofi Pasteur ChengDa PharmaCeuticals Co., Ltd, Berkeley Center for Health Technology, Changsheng Bio-Technology, GSK (Novartis), Chengda,...
GlaxoSmithKline Biologicals, Sanofi Pasteur, Inc., Cadila Pharmaceuticals Ltd., Novartis Vaccines and Diagnostics Ltd., Merck & Co Inc.,...
Top Companies in the Global Tetanus Vaccine Market: Sanofi Pasteur, GSK, Wuhan Institution, , ,, others. Get the inside scoop of the Sample...